fda compounding semaglutide enforcement october 2025 news Diabetes advocacy group discourages use of compounded GLP-1 drugs Compounded Semaglutide & Tirzepatide 2025:

[DOI] [PubMed] 2.Younossi, Z

This is the absolute key to understanding the debate

This remarkable pharmacokinetic synergy makes the combination especially valuable for advanced comparative studies, severe injury-recovery models, and highly complex regenerative research protocols where coordinated, multi-tissue repair is a primary focal point

Insurance Coverage Considerations: Many direct-to-consumer prescription products, including those offered through telehealth platforms, are not covered by traditional insurance plans, but coverage policies vary

dose-finding studies) and commercial ambitions as part of a lifecycle management programme, both of which help to accelerate time to market